Royal Bank of Canada’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.94M | Sell |
27,000
-528,800
| -95% | -$40.7M | ﹤0.01% | 3121 |
|
|
2025
Q4 | $44.1M | Buy |
555,800
+322,400
| +138% | +$25.4M | 0.01% | 1009 |
|
|
2025
Q3 | $17.6M | Buy |
233,400
+33,400
| +17% | +$2.29M | ﹤0.01% | 1746 |
|
|
2025
Q2 | $13.8M | Hold |
200,000
| – | – | ﹤0.01% | 1795 |
|
|
2025
Q1 | $13.6M | Sell |
200,000
-2,200
| -1% | -$132K | ﹤0.01% | 1564 |
|
|
2024
Q4 | $9.08M | Buy |
202,200
+96,700
| +92% | +$5.42M | ﹤0.01% | 1863 |
|
|
2024
Q3 | $6.63M | Buy |
105,500
+102,000
| +2,914% | +$5.95M | ﹤0.01% | 2062 |
|
|
2024
Q2 | $207K | Buy |
+3,500
| New | +$219K | ﹤0.01% | 4741 |
|
|
2023
Q3 | – | Sell |
-150,400
| Closed | -$10.4M | – | 7157 |
|
|
2023
Q2 | $10.4M | Buy |
150,400
+150,000
| +37,500% | +$10.7M | ﹤0.01% | 1556 |
|
|
2023
Q1 | $30K | Sell |
400
-109,100
| -100% | -$9.15M | ﹤0.01% | 5864 |
|
|
2022
Q4 | $10.2M | Buy |
109,500
+20,400
| +23% | +$1.97M | ﹤0.01% | 1584 |
|
|
2022
Q3 | $8.5M | Hold |
89,100
| – | – | ﹤0.01% | 1659 |
|
|
2022
Q2 | $8.26M | Buy |
89,100
+22,500
| +34% | +$2.2M | ﹤0.01% | 1693 |
|
|
2022
Q1 | $6.74M | Sell |
66,600
-379,200
| -85% | -$39.8M | ﹤0.01% | 2011 |
|
|
2021
Q4 | $46M | Hold |
445,800
| – | – | 0.01% | 873 |
|
|
2021
Q3 | $37.8M | Buy |
445,800
+210,000
| +89% | +$17.6M | 0.01% | 905 |
|
|
2021
Q2 | $19.7M | Buy |
235,800
+196,600
| +502% | +$16.1M | 0.01% | 1359 |
|
|
2021
Q1 | $2.95M | Sell |
39,200
-130,800
| -77% | -$9.53M | ﹤0.01% | 2688 |
|
|
2020
Q4 | $11.6M | Buy |
170,000
+30,000
| +21% | +$1.95M | ﹤0.01% | 1609 |
|
|
2020
Q3 | $8.18M | Sell |
140,000
-15,000
| -10% | -$933K | ﹤0.01% | 1675 |
|
|
2020
Q2 | $10.1M | Sell |
155,000
-125,000
| -45% | -$7.87M | ﹤0.01% | 1467 |
|
|
2020
Q1 | $16.6M | Sell |
280,000
-154,400
| -36% | -$10.3M | 0.01% | 1016 |
|
|
2019
Q4 | $32.3M | Buy |
434,400
+72,700
| +20% | +$5.1M | 0.01% | 855 |
|
|
2019
Q3 | $22.8M | Buy |
361,700
+228,300
| +171% | +$13.5M | 0.01% | 1003 |
|
|
2019
Q2 | $7.27M | Buy |
133,400
+129,300
| +3,154% | +$6.96M | ﹤0.01% | 1799 |
|
|
2019
Q1 | $221K | Sell |
4,100
-125,600
| -97% | -$7.75M | ﹤0.01% | 4291 |
|
|
2018
Q4 | $8.5M | Buy |
129,700
+123,400
| +1,959% | +$9.21M | ﹤0.01% | 1608 |
|
|
2018
Q3 | $496K | Sell |
6,300
-128,700
| -95% | -$9.2M | ﹤0.01% | 3905 |
|
|
2018
Q2 | $8.69M | Buy |
+135,000
| New | +$8.9M | ﹤0.01% | 1631 |
|
|
2018
Q1 | – | Sell |
-22,500
| Closed | -$1.63M | – | 6412 |
|
|
2017
Q4 | $1.63M | Sell |
22,500
-39,000
| -63% | -$2.84M | ﹤0.01% | 2891 |
|
|
2017
Q3 | $5M | Buy |
61,500
+39,000
| +173% | +$3.08M | ﹤0.01% | 1991 |
|
|
2017
Q2 | $1.81M | Sell |
22,500
-55,100
| -71% | -$4.35M | ﹤0.01% | 2666 |
|
|
2017
Q1 | $6.09M | Sell |
77,600
-4,900
| -6% | -$391K | ﹤0.01% | 1791 |
|
|
2016
Q4 | $6.51M | Hold |
82,500
| – | – | ﹤0.01% | 1775 |
|
|
2016
Q3 | $7.34M | Sell |
82,500
-43,500
| -35% | -$4.11M | ﹤0.01% | 1679 |
|
|
2016
Q2 | $12.1M | Buy |
126,000
+120,000
| +2,000% | +$12M | 0.01% | 1324 |
|
|
2016
Q1 | $622K | Sell |
6,000
-6,000
| -50% | -$583K | ﹤0.01% | 3463 |
|
|
2015
Q4 | $1.17M | Hold |
12,000
| – | – | ﹤0.01% | 2984 |
|
|
2015
Q3 | $1.16M | Buy |
+12,000
| New | +$1.26M | ﹤0.01% | 2737 |
|
|
2013
Q3 | – | Sell |
-2,000
| Closed | -$114K | – | 6113 |
|
|
2013
Q2 | $114K | Buy |
+2,000
| New | +$116K | ﹤0.01% | 4234 |
|
Other funds holding CVS
VCM
VPM
Royal Bank of Canada's CVS Position: Q1 2026 in Review
Royal Bank of Canada reduced its CVS Health (CVS) stake by 3% in Q1 2026, selling an estimated $21.3M and leaving 8,984,614 shares worth $645M. The position accounts for 0.11% of the portfolio, ranked #173.
Royal Bank of Canada first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.56B in Q4 2021. 1,874 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Royal Bank of Canada held 8,984,614 shares of CVS Health worth $645M as of Q1 2026.
- Royal Bank of Canada sold 276,841 CVS Health shares in Q1 2026, an estimated $21.3M.
- CVS Health made up 0.11% of Royal Bank of Canada's portfolio in Q1 2026, its #173 holding.
- Royal Bank of Canada first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's CVS Health position peaked at $1.56B in Q4 2021.
- 1,874 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.